The federal government’s most consequential move in today’s Federal Register was the absence of an immediate tariff: a presidential proclamation concluded a Section 232 investigation into robotics and industrial machinery imports by directing trade negotiations rather than imposing duties or quotas, at least for now.
- Executive Office of the President: Proclamation 11077, signed October 28 and published today, found that imports of robotics and industrial machinery threaten national security under Section 232 of the Trade Expansion Act, since the United States produces less of this equipment than it consumes and much of what it imports can touch sensitive data. Rather than impose the tariffs or quotas that have followed many other Section 232 findings in recent years, the proclamation directs the Secretary of Commerce and the U.S. Trade Representative to pursue negotiations with trading partners first, with a progress report due within 180 days, around late April 2027. Choosing negotiation over immediate tariffs is the less common path for this administration’s Section 232 findings, which makes the next few months of trade talks worth watching.
- Food and Drug Administration: FDA proposed the first comprehensive revision of infant formula nutrient requirements since 1998, part of its Operation Stork Speed initiative, with changes to the required minimums and maximums for iodine, vitamin A, vitamin D, and manganese. The rule opens a 120-day comment window, which gives pediatricians, formula manufacturers, and parents a chance to weigh in before any of the revised nutrient levels could become binding on what’s sold on store shelves.
- Employee Benefits Security Administration (Labor Department): The agency finalized its rule requiring pharmacy benefit managers and their affiliated brokers to disclose, in detail and in advance, the compensation they receive from large employer health plans, so that plan fiduciaries can judge whether those arrangements are reasonable under ERISA. The rule takes legal effect 60 days after publication, but compliance isn’t required until plan years beginning July 1, 2027, so employers and PBMs get roughly eight additional months beyond the rule’s nominal effective date to renegotiate contracts and build reporting systems before the disclosure duty actually bites.
- Department of the Treasury / Department of State: A presidential memorandum delegated authority under Section 8335 of the fiscal year 2026 National Defense Authorization Act, which made it mandatory, rather than discretionary, for the administration to impose sanctions on people who threaten the peace or territorial integrity of the Western Balkans, and which limits how the President can later lift those sanctions. The memorandum hands day-to-day implementation to the Treasury Secretary, consulting with the Secretary of State, which matters because Congress wrote this sanctions regime specifically to constrain an executive discretion it apparently didn’t trust on this particular question.
- Drug Enforcement Administration: DEA corrected its own regulations to replace outdated fixed-dollar fines, as low as $30,000 in some provisions, with the updated title 18 cross-reference Congress actually enacted back in 2002. The agency invoked the Administrative Procedure Act’s good-cause exception to skip the usual notice-and-comment process and make the fix effective immediately on publication, reasoning that it has no discretion to apply anything but the statute. That reasoning may well be sound, but it’s also an acknowledgment that a known, purely clerical mismatch between regulation and statute sat uncorrected for 24 years until today.
- Office of Management and Budget (Made in America Office): OMB reopened, at industry’s request, the comment period on its request for information about domestic and near-shore manufacturing capacity for medicines on the ASPR 86 List of essential drugs, pushing the deadline from October 26 to November 27. A reopened window like this one, meant to feed data on idle U.S. and near-shore drug production capacity into pandemic-preparedness and supply-chain planning, is routine enough on its own, but it also suggests the original one-month collection period wasn’t long enough for manufacturers to assemble the figures OMB is asking for.
This issue of the Federal Register ran to roughly 100 documents across more than 60 agencies and sub-agencies, by our count of today’s official table of contents. We set aside routine information-collection and Paperwork Reduction Act notices, antidumping and countervailing-duty sunset reviews and investigations from the International Trade Administration and International Trade Commission, Foreign-Trade Zone subzone and production-authorization notices, Sunshine Act meeting announcements, and FAA airworthiness directives that raised no unusual issues.
